Form EFFECT XORTX Therapeutics Inc.

May 14, 2026 6:09 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 13, 2026
Accession Number: 0001104659-26-057834
Submission Type: POS AM
CIK: 0001729214
Company Name: XORTX Therapeutics Inc.
File Number: 333-290512


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings